The results demonstrate that addition of IGF-I also significantly increased activity of caspase 3/7 (figure 2a), 8 (figure 2b) and 9 (figure 2c) in HCT-116 CRC cells in both SCM and SFM conditions. The gene discussed is IGF1; the disease is colorectal carcinoma.